Self monitoring blood glucose

DEVICE4 trials

Sponsors

HealthPartners Institute, Insel Gruppe AG, University Hospital Bern, Vastra Gotaland Region, Brigham and Womens Hospital

Conditions

Diabetes Type 2Gestational DiabetesNutritional, Metabolic, Endocrine PaediatricsType 1 Diabetes

Unknown Phase

Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)

CompletedNCT02074384

HealthPartners InstituteType 1 Diabetes

Start: 2014-03-31End: 2015-07-31Updated: 2016-03-28

Implementation of home glucose meter use for insulin dependent Type 1 and 2 Diabetes patients in rural districts in Rwanda

Active, not recruitingPACTR201905538846394

Brigham and Womens HospitalNutritional, Metabolic, Endocrine Paediatrics

Start: 2019-06-10Target: 90Updated: 2026-09-14

Utility of Real Time Continuous Glucose Monitoring in the Care of Gestational Diabetes Versus Standard Care in Pregnancy Outcomes

CompletedNCT05037526

Insel Gruppe AG, University Hospital BernGestational Diabetes

Start: 2021-09-24End: 2024-10-30Updated: 2024-12-16

The Effect of Continuous Glucose Monitoring in Individuals With Newly Diagnosed Type 2 Diabetes

Not yet recruitingNCT06471699

Vastra Gotaland RegionDiabetes Type 2

Start: 2024-11-01End: 2030-12-31Target: 250Updated: 2024-06-24

Related Papers

Continuous glucose monitoring in the management of gestational diabetes in Switzerland (DipGluMo): an open-label, single-centre, randomised, controlled trial.

2025-05-269 citations

Feasibility and effectiveness of self-monitoring of blood glucose among insulin-dependent patients with type 2 diabetes: open randomized control trial in three rural districts in Rwanda

BMC Endocrine Disorders2022-10-0811 citations

Implementation of blood glucose self-monitoring among insulin-dependent patients with type 2 diabetes in three rural districts in Rwanda: 6 months open randomised controlled trial

BMJ Open2020-07-017 citations